How Brands and Retailers Should Strategically Respond to the GLP-1 Consumer Boom

Why It Matters

GLP‑1 adoption creates a permanent, high‑margin consumer segment that will redefine category performance and supply‑chain planning for retailers, making early strategic alignment a competitive imperative.

Key Takeaways

• GLP-1 market to hit $137 B by 2030
• Smaller baskets, higher spend on health‑focused items
• Private‑label GLP-1 products attract 77% of users
• Apparel sizing must adapt to rapid weight loss
• Pharmacies become wellness hubs, driving grocery traffic

Pulse Analysis

The explosion of GLP‑1 therapeutics—driven by drugs such as Ozempic, Wegovy and Mounjaro—is more than a medical trend; it is a macroeconomic force reshaping consumer spending. Analysts forecast an 18% compound annual growth rate, pushing market size to $137 billion by 2030. This growth is underpinned by expanded insurance coverage, improved manufacturing capacity, and the rollout of oral and multi‑benefit formulations, which together lower barriers to adoption and broaden the demographic reach of weight‑loss and metabolic‑health solutions.

Retailers are witnessing a pronounced shift in basket composition. While total unit counts decline, average spend per transaction rises as shoppers gravitate toward protein‑rich foods, functional supplements, and premium wellness products. Private‑label offerings tailored to GLP‑1 users are gaining traction, with 77% indicating willingness to purchase store‑brand formulations that support their therapy. Apparel merchants must also recalibrate size curves and introduce flexible services—such as fit‑tools, alterations, and swap programs—to retain customers experiencing rapid weight changes. Meanwhile, pharmacies are evolving from pure dispensing points into integrated wellness hubs, linking prescriptions to curated assortments, home‑delivery, and digital health support.

To capitalize on this emerging landscape, Coresight proposes the SPARK framework: Shift focus to high‑margin health categories, Position private‑label GLP‑1 lines, Adjust apparel sizing, Reimagine pharmacies as loyalty centers, and Keep in‑store food services protein‑centric and portion‑controlled. Brands that act now—by simplifying choice, enhancing labeling, and embedding technology‑enabled personalization—will secure loyalty and capture incremental revenue as GLP‑1 becomes a fixture of everyday consumer behavior.